European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study

Launched by UNIVERSITY OF KIEL · Jan 29, 2021

Keywords

ClinConnect Summary

The European TauroPace Registry study is looking into the safety and effectiveness of a device called TauroPace™ during procedures for patients who need cardiac implantable electronic devices (CIEDs), such as pacemakers. The study is being conducted at the University of Schleswig-Holstein and aims to include at least 2,300 procedures. This research focuses on patients who are having new devices placed or existing devices revised, and it will help doctors understand how well the TauroPace™ device works in these situations.

To be eligible for this study, participants must be 18 years or older and scheduled for a surgery involving a CIED where the use of TauroPace™ is appropriate. Participants will need to provide consent to join the study, ensuring they understand its purpose. Throughout the study, participants can expect to receive standard care during their procedures, and their experiences will be monitored to gather important safety information. This trial is currently recruiting and is open to all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Use of TauroPace™ is indicated and not contra-indicated according to its current Instructions For Use (IFU)
• • Participant is eligible for a CIED related surgery procedure.
• Exclusion Criteria:
• • Age\<18years
• • Participant incapable of signing Patient Informed Consent (mentally or physically) or does not sign.